Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI

Overview of attention for article published in Frontiers in Pharmacology, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Mitigation of myocardial ischemia/reperfusion–induced chronic heart failure via Shexiang Baoxin Pill–mediated regulation of the S1PR1 signaling pathway

Article in Phytomedicine (January 2024)

Optimized gated a SPECT-derived myocardial salvage index: its prognostic significance in predicting major adverse cardiac events following acute myocardial infarction percussion

Article in Annals of Nuclear Medicine (January 2024)

The Shexiang Baoxin Pill Protects Myocardial Cells from Multiple Targets of MIRI through the PI3K/Akt/eNOS Signal Pathway

Preprint in bioRxiv (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.